These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 34520038)

  • 1. Rapid microinduction of sublingual buprenorphine from methadone in an outpatient setting: "A case series".
    Singh G; Sri Konakanchi J; Betsch B; Thapa A; Sethi R
    J Opioid Manag; 2021; 17(7):167-170. PubMed ID: 34520038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outpatient Rapid Microinduction of Sublingual Buprenorphine in 3 Days From Methadone for Opioid Use Disorder.
    Salapenka I; Konakanchi JS; Sethi R
    Prim Care Companion CNS Disord; 2022 Dec; 24(6):. PubMed ID: 36584361
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid Transition From Methadone to Buprenorphine Utilizing a Micro-dosing Protocol in the Outpatient Veteran Affairs Setting.
    De Aquino JP; Fairgrieve C; Klaire S; Garcia-Vassallo G
    J Addict Med; 2020; 14(5):e271-e273. PubMed ID: 32011408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating opioid use disorder with rapid micro induction technique of sublingual buprenorphine/naloxone in an outpatient setting-a case report.
    Martell JP; Konakanchi JS; Sethi R
    J Addict Dis; 2022; 40(3):439-443. PubMed ID: 35072589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting.
    Carswell N; Angermaier G; Castaneda C; Delgado F
    Hosp Pract (1995); 2022 Oct; 50(4):251-258. PubMed ID: 35837678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose buprenorphine initiation in the era of fentanyl and fentanyl analogs: A case series of outpatient inductions.
    Ahmed S; Faruqui Z; Poddar K; Bhivandkar S; Suzuki J
    J Opioid Manag; 2023; 19(5):455-460. PubMed ID: 37968979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine Microdosing Cross Tapers: A Time for Change.
    Raheemullah A; Benhamou OM; Kuo J; Lembke A
    Int J Environ Res Public Health; 2022 Dec; 19(24):. PubMed ID: 36554317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitioning Hospitalized Patients with Opioid Use Disorder from Methadone to Buprenorphine without a Period of Opioid Abstinence Using a Microdosing Protocol.
    Terasaki D; Smith C; Calcaterra SL
    Pharmacotherapy; 2019 Oct; 39(10):1023-1029. PubMed ID: 31348544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microinduction to Buprenorphine from Methadone for Chronic Pain: Outpatient Protocol with Case Examples.
    Jasmine Silva M; Coffee Z; Goza J; Rumrill K
    J Pain Palliat Care Pharmacother; 2022 Mar; 36(1):40-48. PubMed ID: 35290161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transitioning From High-dose Methadone to Buprenorphine Using a Microdosing Approach: Unique Considerations at ASAM Level 3 Facilities.
    Anderson C; Cooley R; Patil D
    J Addict Med; 2023 Mar-Apr 01; 17(2):241-244. PubMed ID: 36161824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Uses of Methadone Under the "72-Hour Rule" to Facilitate Transitions of Care and Low-Dose Buprenorphine Induction in an Outpatient Bridge Clinic.
    Shahlapour M; Singh S; Christine PJ; Laks J; Evans J; Farrell NM; Khan GK; Taylor JL; Rozansky H
    J Addict Med; 2024 May-Jun 01; 18(3):345-347. PubMed ID: 38329815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting - a case series.
    Soyka M; Groß G
    Am J Drug Alcohol Abuse; 2021 Sep; 47(5):599-604. PubMed ID: 34407703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methadone Induction for a Patient With Precipitated Withdrawal in the Emergency Department: A Case Report.
    Church B; Clark R; Mohn W; Potee R; Friedmann P; Soares WE
    J Addict Med; 2023 May-Jun 01; 17(3):367-370. PubMed ID: 37267195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inpatient Low-dose Transitions From Full Agonist Opioids Including Methadone Onto Long-acting Depot Buprenorphine: Case Series From a Multicenter Clinical Trial.
    Seval N; Nunez J; Roth P; Schade M; Strong M; Frank CA; Litwin AH; Levin FR; Brady KT; Nunes EV; Springer SA
    J Addict Med; 2023 Jul-Aug 01; 17(4):e232-e239. PubMed ID: 37579095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medications for management of opioid use disorder.
    Koehl JL; Zimmerman DE; Bridgeman PJ
    Am J Health Syst Pharm; 2019 Jul; 76(15):1097-1103. PubMed ID: 31361869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration and patient-incurred costs associated with opioid agonist treatment in Norway.
    Pedersen MH; Danø A; Gibbons C; Jensen R
    Curr Med Res Opin; 2022 Nov; 38(11):1959-1965. PubMed ID: 36172758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community based buprenorphine micro-induction in the context of methadone maintenance treatment and fentanyl - Case report.
    Kaliamurthy S; Jegede O; Hermes G
    J Addict Dis; 2023; 41(2):175-180. PubMed ID: 35377273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological treatment of opioid use disorder in pregnancy.
    Rodriguez CE; Klie KA
    Semin Perinatol; 2019 Apr; 43(3):141-148. PubMed ID: 30755340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine and methadone for opioid addiction during pregnancy.
    Mozurkewich EL; Rayburn WF
    Obstet Gynecol Clin North Am; 2014 Jun; 41(2):241-53. PubMed ID: 24845488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
    Jordan CJ; Cao J; Newman AH; Xi ZX
    Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.